Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Aug 30;91(18):8562-6.
doi: 10.1073/pnas.91.18.8562.

Divergent T-cell cytokine patterns in inflammatory arthritis

Affiliations

Divergent T-cell cytokine patterns in inflammatory arthritis

A K Simon et al. Proc Natl Acad Sci U S A. .

Abstract

A major immunoregulatory mechanism in inflammatory infections and allergic diseases is the control of the balance of cytokines secreted by Th1/Th2 subsets of T helper (Th) cells. This might also be true in autoimmune diseases; a Th2 pattern that prevents an effective immune response in infections with intracellular bacteria may favor immunosuppression in autoimmune disease. The pattern of cytokine expression was compared in the synovial tissue from patients with a typical autoimmune disease, rheumatoid arthritis, and with a disorder with similar synovial pathology but driven by persisting exogenous antigen, reactive arthritis. We screened 12 rheumatoid and 9 reactive arthritis synovial tissues by PCR and in situ hybridization for their expression of T-cell cytokines. The cytokine pattern differs significantly between the two diseases; rheumatoid arthritis samples express a Th1-like pattern whereas in reactive arthritis interferon gamma expression is accompanied by that of interleukin 4. Studying the expression of cytokines by in situ hybridization confirmed the results found by PCR; they also show an extremely low frequency of cytokine-transcribing cells. In a double-staining experiment, it was demonstrated that interleukin 4 is made by CD4 cells. These experiments favor the possibility of therapeutic intervention in inflammatory rheumatic disease by means of inhibitory cytokines.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Immunol. 1992 Jun;22(6):1615-20 - PubMed
    1. Annu Rev Immunol. 1992;10:453-88 - PubMed
    1. Gut. 1992 Jul;33(7):933-7 - PubMed
    1. Immunol Rev. 1992 Jun;127:183-204 - PubMed
    1. J Exp Med. 1992 Oct 1;176(4):1091-8 - PubMed

Publication types

MeSH terms